Limitations of VS38c labeling in the detection of plasma cell myeloma by flow cytometry

Author:

Czeti Ágnes1ORCID,Szalóki Gábor1ORCID,Varga Gergely2,Szita Virág Réka2,Komlósi Zsolt István3,Takács Ferenc1ORCID,Márk Ágnes1,Timár Botond1,Matolcsy András1,Barna Gábor1ORCID

Affiliation:

1. First Department of Pathology and Experimental Cancer Research, Faculty of Medicine Semmelweis University Budapest Hungary

2. Department of Internal Medicine and Haematology, Faculty of Medicine Semmelweis University Budapest Hungary

3. Department of Genetics, Cell‐ and Immunobiology, Faculty of Medicine Semmelweis University Budapest Hungary

Funder

Semmelweis Egyetem

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference29 articles.

1. Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management

2. Multiple myeloma

3. Assessment of response to therapy in multiple myeloma by multiparameter flow cytometry. Usefulness of an eight‐color single tube with monoclonal antibodies in dried formulation;Carulli G;Clin Ter,2019

4. Minimal residual disease in multiple myeloma: Benefits of flow cytometry

5. Immunophenotyping in multiple myeloma and related plasma cell disorders

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3